Go to deals
Healthcare | Private Equity

GMD PharmaSolutions has been acquired by McKesson Corporation

GMD PharmaSolutions, a portfolio company of Hammond, Kennedy, Whitney & Company (HKW), has been sold to McKesson Corporation for an undisclosed consideration.

GMD PharmaSolutions provides a one-stop solution for the management and distribution of pharmaceuticals, biological and medical devices in Canada.

McKesson is the oldest and largest healthcare company in the nation, serving more than 50% of US hospitals and 20% of physicians. The company delivers one third of all medications used daily in North America and has operations in more than 16 countries. McKesson's state-of-the-art network of distribution centers are strategically located across the USA, storing thousands of branded, generic and specialty pharmaceuticals and over-the-counter products from manufacturers around the globe. Its sophisticated online ordering platform and tools ensure availability, accuracy, on-time delivery and barcode tracking.

HKW is a private equity firm specializing in investments in later stage, mature, management buy-outs of privately owned businesses, subsidiaries, and divisions of corporations and public companies; industry consolidations; corporate divestitures; generational changes in ownership; recapitalization transactions; and growth equity investments. The firm seeks to invest in small middle-market companies with low risk of technological obsolescence. HKW is a generalist that seeks to invest in the medical devices, aerospace and defense, water infrastructure, oil and natural gas, telecommunication services, information technology, materials, specialty and recreational vehicles, automation processing equipment, industrial burners and combustion equipment, financials, healthcare, energy, nuclear, coal, niche manufacturing, and utility related infrastructure, with a focus on industrial manufacturing, services, and distribution companies. The firm prefers to invest in companies headquartered in North America. It seeks to invest from US$5 to more than US$150 million in companies having an enterprise value between US$10–175 million, generating revenues between US$20–200 million, with an EBITDA between US$2–30 million, and having operating cash flow of at least US$2 million. The platform transaction range is between US$20 to over US$150 million with no minimum for add-on acquisitions. It typically makes equity investments that result in acquisition of control and does not have a minimum criterion for add-on acquisitions.

One of Oaklins' member firms in the USA served as the exclusive financial advisor to GMD PharmaSolutions in its sale to McKesson Corporation.

Service
M&A sell-side
Parties

Talk to the deal team

 Michael S. Goldman

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital
 Paul R. Smolevitz

Paul R. Smolevitz

Managing Director
New York, United States
Oaklins TM Capital
 Vidur  Kapur

Vidur Kapur

Associate Director
New York, United States
Oaklins TM Capital

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
IJssel Technologie agrees to sell the company to Argos Wityu
Private Equity | Business Support Services

IJssel Technologie agrees to sell the company to Argos Wityu

The shareholders of IJssel Technologie have agreed to sell a majority stake in the company to Argos Wityu. By partnering with Argos Wityu, IJssel Technologie welcomes a strong new shareholder that will help strengthen the company’s market-leading position and together will further improve IJssel Technologie’s service offering to address the relevant macro-economic developments, including the trend toward sustainable and smart industries.

Learn more
Brookdale Treeland Nurseries has sold a majority stake to Rouge River Capital
Private Equity | Agriculture

Brookdale Treeland Nurseries has sold a majority stake to Rouge River Capital

The shareholders of Brookdale Treeland Nurseries have sold a controlling stake to Rouge River Capital.

Learn more